LAKE SUCCESS, NY – November 27, 2023 – Local health care providers, cancer survivors, and patient advocates gathered today at the Northwell Health Cancer Institute to call on Governor Kathy Hochul to prioritize health equity by improving access to biomarker testing and signing Se
NEW YORK, NY – November 16, 2023 – Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope
Earlier today, the legislative sponsors of Senate Bill 954 and House Bill 1754 joined patient advocates, cancer survivors and medical leaders at the state Capitol and urged their colleagues in the House and Senate to support legislation improving Pennsylvanians’ access to biomarker testing.
BUFFALO, NY – November 8, 2023 – Earlier today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable,
HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week.
El gobernador de California, Gavin Newsom, anunció que promulgó el Proyecto de Ley del Senado 496 para garantizar que más planes de seguro médico, incluido Medi-Cal, cubran las pruebas integrales de biomarcadores cuando estén respaldadas por evidencia médica y científica.
FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild.
TRENTON, NJ – AUGUST 4, 2023 – Earlier this week, cancer survivors, caregivers and advocates from across New Jersey accompanied the American Cancer Society Cancer Action Network (ACS CAN) to the State House for tips on advocacy and a briefing on the importance of biomarker testing in cancer care.
La Asamblea del Estado de Nueva York aprobó el Proyecto de Ley 1673a de la Asamblea para aumentar el acceso a las pruebas de biomarcadores, que pueden ayudar a determinar el mejor plan de tratamiento para cada paciente.
Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.